Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Wellorithm Review
Its Wegovy page says the drug is FDA-approved for type 2 diabetes. So does its Zepbound page. Neither is — and that tells you how carefully these pages were checked before being used to sell prescription medicine.
Wellorithm
Incorrect Drug IndicationsWellorithm is a GLP-1 telehealth platform launched in 2026, offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro, in all 50 states, with HSA and FSA accepted and free shipping.
The finding that sets the rating: the Wegovy and Zepbound pages both describe the drug as “FDA-approved for the treatment of type 2 diabetes and improved glycemic control”. Neither is. Wegovy is approved for chronic weight management and cardiovascular risk reduction; Zepbound for chronic weight management and obstructive sleep apnoea. The diabetes products are Ozempic and Mounjaro. The same boilerplate sits on all four pages and happens to be right on two.
Pricing is the second problem. Wegovy $899, Ozempic and Zepbound around $1,199, Mounjaro $1,399 — against $299 a month cash at Amazon Pharmacy for the same approved Wegovy and Zepbound, which we verified and published this month. The compounded pricing, from $249 with $100 off the first month, is competitive. The brand pricing is not.
Credit where it is due: the weight-loss guarantee is not just a slogan. The terms define it — fail to lose 10% of baseline weight after 16 weeks of documented adherence and you may recover up to four months of fees. Compounded products are labelled as compounded, cancellation is available any time by email, and the arbitration clause is disclosed plainly.
Affiliate disclosure: GLP1Drugs.org earns a commission if you sign up through this page — $400 by default and $500 for a brand-name GLP-1, the largest payouts in our entire queue. You should weigh that when reading this or any other review of this company, and note that most of the search results about it are affiliate pages. We have rated it 2.5. Verified 7 August 2026.
Visit WellorithmOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
2 of 4
Brand Pages With Wrong Indications
28 days
Billing Cycle — 13 Charges A Year
1
Trustpilot Review, Not 100,000
$500
Commission Per Brand Signup
What The Drug Pages Get Wrong
Checked page by page on 7 August 2026.
Wegovy Is Not A Diabetes Drug
Its page says 'FDA-approved for the treatment of type 2 diabetes and improved glycemic control'. Wegovy is approved for chronic weight management and, since March 2024, cardiovascular risk reduction
Nor Is Zepbound
The same sentence appears on the Zepbound page, which also states 'Zepbound® is FDA-approved for type 2 diabetes'. Zepbound is approved for chronic weight management and obstructive sleep apnoea in obesity
The Boilerplate Gives It Away
The identical description sits on all four brand pages. It happens to be correct for Ozempic and Mounjaro, which are the diabetes products, and wrong for the two weight-management ones
Why It Matters
This is not marketing puffery. It is an incorrect statement of what a prescription medicine is approved to treat, on the page selling that medicine
What It Suggests
Four drug pages built from one template without anyone clinically reviewing the output — which is the deeper concern for a company prescribing these drugs
Get It Right Elsewhere
Ozempic and Mounjaro are approved for type 2 diabetes. Wegovy and Zepbound are approved for weight management. Prescribing across those lines happens, but it is off-label and should be described as such
Indication, Price, Reality
What each page claims, what the medicine is actually approved for, and what it costs here versus elsewhere.
| Drug | Page says | Actually approved for | Here / Amazon |
|---|---|---|---|
| Wegovy | Type 2 diabetes | Chronic weight management; CV risk reduction | $899 / $299 |
| Zepbound | Type 2 diabetes | Chronic weight management; obstructive sleep apnoea | ~$1,199 / $299 |
| Ozempic | Type 2 diabetes | Type 2 diabetes — correct | ~$1,199 |
| Mounjaro | Type 2 diabetes | Type 2 diabetes — correct | $1,399 |
| Compounded | Labelled as compounded — to their credit | Not FDA-approved at all | From $249, $149 first month |
The Amazon Pharmacy figures come from our own review published this month. If you want the branded medicine, read that first.
Pros & Cons
Pros
- ✓The weight-loss guarantee is written into the terms rather than left as a slogan: fail to lose 10% of baseline weight after 16 weeks of documented medication adherence and you may be eligible for a refund of up to four months of fees
- ✓Cancellation is available at any time by email, with no lock-in period stated
- ✓Serves all 50 states, with HSA and FSA accepted and free expedited shipping advertised
- ✓Both compounded and brand-name options are offered, rather than compounded only
- ✓Compounded entry pricing is competitive: from $249 a month with $100 off the first month, and a $147 promotional entry rate
- ✓The terms and conditions exist, are linked from the footer, and disclose the binding arbitration and class-action waiver plainly
- ✓No membership or hidden consultation fee is charged on top of the medication price
Cons
- ✕The Wegovy and Zepbound pages both state the drug is FDA-approved for type 2 diabetes. Neither is
- ✕Brand-name pricing is far above the market: Wegovy $899, Ozempic and Zepbound around $1,199, Mounjaro $1,399 — against $299 a month cash at Amazon Pharmacy
- ✕Billing runs every 28 days rather than monthly, which is 13 charges a year, not 12
- ✕Payments are 'non-refundable once processed', and cancelling does not refund the cycle you are in
- ✕'Join 100,000+ Wellorithm patients' is unsourced; Trustpilot holds a single review for the domain
- ✕No dispensing pharmacy is named anywhere, and no prescribing clinician is identified
- ✕The affiliate programme launched in April 2026, so there is essentially no independent track record
- ✕Affiliate commissions run to $500 per brand-name signup — the highest in our queue, and worth knowing when you read any review of this company
- ✕Claiming the guarantee requires you to evidence adherence, and the refund is processed only after verification
Our Verdict
2.5 / 5 — a platform with a genuinely well-drafted guarantee and competitive compounded pricing, selling prescription medicines from pages that misstate what two of them are approved to treat.
Some of this is done properly and we will say so. The weight-loss guarantee is written into the terms with a defined threshold and payout rather than left as a slogan. Compounded products are labelled as compounded, which is more than several platforms the FDA has written to manage. Cancellation is available any time by email, the arbitration clause is disclosed, the service covers all 50 states, and the compounded entry pricing at $249 with $100 off the first month is competitive with the mid-market.
None of that survives the drug pages. Telling a prospective patient that Wegovy and Zepbound are FDA-approved for type 2 diabetes is not a turn of phrase — it is wrong about what the medicine is for, published on the page that sells it, and it is wrong twice in the same way because one description was pasted across four products without clinical review. For a company whose entire proposition is that licensed professionals will assess you and prescribe appropriately, that is the wrong error to make. Around it sit brand prices up to four times Amazon Pharmacy's cash rate, a 28-day billing cycle that quietly produces thirteen charges a year, an unsourced claim of 100,000 patients against a single Trustpilot review, and no named pharmacy or prescriber. Our advice: if you want branded medication, buy it somewhere cheaper and better documented. If the compounded pricing appeals, ask who fills the prescription and who signs it before you pay — and do not take this site's word for what any of these drugs are approved to do.
Visit WellorithmFrequently Asked Questions
What exactly is wrong on the drug pages?
Two of the four brand-name pages misstate what the medicine is approved to treat, and we checked each one. The Wegovy page carries the description 'FDA-approved for the treatment of type 2 diabetes and improved glycemic control'. That is incorrect: Wegovy is FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related comorbidity, and since March 2024 for reducing cardiovascular risk in adults with established cardiovascular disease and overweight or obesity. It is not approved for type 2 diabetes. The Zepbound page carries the identical sentence, and adds 'Zepbound® is FDA-approved for type 2 diabetes, improving glycemic control'. Also incorrect: Zepbound is approved for chronic weight management and, separately, obstructive sleep apnoea in adults with obesity. The diabetes products are Ozempic and Mounjaro, whose pages say the same thing and are right to. The pattern is clear — one boilerplate description pasted across four pages, correct on two of them by coincidence. Clinicians do prescribe across these lines, but that is off-label use and should be described that way rather than stated as an approval that does not exist.
Does that make the medication unsafe?
No, and we want to be precise rather than alarmist. Wegovy and Zepbound are real, FDA-approved medicines and nothing about a website's copy changes what is in the pen. If you are prescribed either through this platform you are getting the same branded product you would get anywhere. The problem is informational, and it matters in two ways. First, a patient reading that page could reasonably come away believing their weight-management medication is a diabetes treatment, which affects how they understand their own care and what they tell other clinicians. Second, and more importantly for anyone deciding whether to sign up, it tells you something about the operation: the pages selling prescription drugs were assembled from a template and published without anyone with clinical knowledge checking them. That is a reasonable thing to weigh when choosing who prescribes for you.
What does it cost?
Checked on 7 August 2026, compounded plans started at $249 a month with $100 off the first month, alongside a promotional entry price of $147. Those compounded rates are competitive with the mid-market. The brand-name pricing is where it becomes difficult: Wegovy at $899 a month, Ozempic and Zepbound at around $1,199, and Mounjaro at $1,399. For comparison, and verified in our own review published this month, Amazon Pharmacy sells FDA-approved Wegovy and Zepbound at $299 a month cash with no membership required. Buying Zepbound here rather than there would cost roughly four times as much for the identical medicine. Nothing in the service explains that gap. If you want the branded product, price it elsewhere first.
How does the billing work?
Every 28 days, which is not the same as monthly and is worth spotting before you sign up. The terms state that 'membership fees are billed every 28 days, and payments are non-refundable once processed'. A 28-day cycle produces thirteen charges in a year rather than twelve, so the effective annual cost is about 8% higher than a monthly figure implies. On a $249 plan that is roughly $250 a year of difference you would not get from multiplying by twelve. You can cancel at any time by email, but 'costs for the current cycle are not refunded once made', so cancel before the next cycle bills rather than after. None of this is hidden — it is written plainly in the terms — but it is not on the pricing page either.
Is the weight-loss guarantee real?
More real than most, and more demanding than it sounds. The marketing says simply 'we guarantee you'll lose weight'. The terms set out what that actually means: if you do not lose at least 10% of your baseline weight after 16 weeks of medication adherence, you may be eligible for a refund of up to four months of fees, with the refund processed within 30 days of verification. Credit where it is due — that is a defined, falsifiable commitment with a stated threshold and payout, which is more than most platforms offer. Read the conditions, though. Ten percent in 16 weeks is a demanding bar to fall short of, so many people will not qualify simply because the medication worked. The onus is on you to evidence adherence, and the refund is capped at fees paid and subject to a verification process the company runs. Treat it as a genuine backstop against total non-response, not as a general satisfaction guarantee.
Who prescribes and who dispenses?
We could not find out, and that is a meaningful gap. The site says a 'team of licensed professionals will review your information' and that it serves all 50 states, but it names no prescribing clinician, publishes no NPI numbers, and identifies no dispensing pharmacy anywhere we looked. Compare that with the better platforms in this category, some of which list their pharmacies with phone numbers and publish prescriber NPIs you can check against the federal registry. For compounded medication in particular, the pharmacy is the single most important thing to know — it is the entity actually making what you inject. Ask before you pay: which pharmacy fills my prescription, is it a 503A or 503B facility, and who is the prescribing clinician.
Is compounded semaglutide the same as Wegovy?
No. Compounded medications are prepared by licensed pharmacies against individual prescriptions. They are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound beyond sharing an active ingredient. The efficacy figures the category cites — a mean 14.9% body-weight reduction at 68 weeks in STEP 1, 20.9% at 72 weeks in SURMOUNT-1 — come from trials of the approved branded products, not compounded copies. Wellorithm does label its compounded products as compounded, which is to its credit and better than several platforms the FDA has written to. Since neither semaglutide nor tirzepatide is currently in shortage, ask what clinical basis supports compounding in your particular case.
Who should not use this?
GLP-1 receptor agonists are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in anyone who has had a serious hypersensitivity reaction to them. They must not be used in pregnancy, when trying to conceive, or while breastfeeding. Common side effects are nausea, vomiting, diarrhoea and constipation, typically worst during dose escalation; more serious risks include pancreatitis, gallbladder disease and kidney injury from dehydration. Tell the prescriber about any history of pancreatitis, gallbladder disease, severe gastrointestinal disease, diabetic retinopathy or kidney impairment. And given what we found on the drug pages, do not rely on this site's descriptions for what your medication is or does — read the manufacturer's own labelling and ask your prescriber. This page is information, not medical advice.
Ask Who Fills It And Who Signs It
No pharmacy or prescriber is named. If the compounded pricing appeals, get both in writing before you pay — and price branded medication elsewhere first.
Visit WellorithmCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Mochi Health
Obesity Medicine SpecialistsBoard-certified obesity medicine specialists with both brand-name and compounded GLP-1 options
Read Review →Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →Medical Disclaimer: This page is for information only and is not medical advice. Always consult a licensed clinician before starting or changing treatment, and rely on the manufacturer's approved labelling rather than a seller's website for what a medicine is indicated to treat. Compounded medications are not FDA-approved, are not evaluated by the FDA for safety, effectiveness or quality, and are not equivalent to Ozempic, Wegovy, Mounjaro or Zepbound beyond a shared active ingredient. GLP-1 receptor agonists commonly cause nausea, vomiting, diarrhoea and constipation, and carry risks including pancreatitis, gallbladder disease and kidney injury; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and must not be used in pregnancy, when trying to conceive, or while breastfeeding. Prescribing depends on clinician approval and state regulation and is not guaranteed. No weight-loss outcome is promised by this site; efficacy figures cited are from STEP 1 and SURMOUNT-1, which studied approved branded products in trial populations.
Date reviewed: 7 August 2026. Prices, the all-50-states and HSA/FSA statements, and the quoted product descriptions were read from Wellorithm's own pages on that date and may change. The descriptions 'FDA-approved for the treatment of type 2 diabetes and improved glycemic control' on the Wegovy and Zepbound pages, and 'Zepbound® is FDA-approved for type 2 diabetes, improving glycemic control', were captured from those pages the same day. For the record: Wegovy is FDA-approved for chronic weight management and, since March 2024, for cardiovascular risk reduction in adults with established cardiovascular disease and overweight or obesity; Zepbound is approved for chronic weight management and for obstructive sleep apnoea in adults with obesity; Ozempic and Mounjaro are the products approved for type 2 diabetes. Billing terms — fees billed every 28 days, non-refundable once processed, cancellation any time by email with the current cycle not refunded — and the weight-loss guarantee, requiring a failure to lose at least 10% of baseline weight after 16 weeks of medication adherence for a refund of up to four months of fees within 30 days of verification, were quoted from the company's terms and conditions. Trustpilot listed a single review for wellorithm.com, too few to quote a meaningful score; the '100,000+ patients' figure is the company's own and unverified. We found no FDA warning letter issued to this company and no named dispensing pharmacy or prescribing clinician on the site. The Amazon Pharmacy comparison comes from our own review published this month.
Affiliate Disclosure: This site may receive compensation from affiliate partners. Commissions on this programme are $400 by default and $500 for brand-name GLP-1 signups. This does not influence our editorial content or review ratings.